Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 20 points (-0.2%) at 12,795 as of Monday, Nov. 12, 2012, 11:49 AM ET. The NYSE advances/declines ratio sits at 1,283 issues advancing vs. 1,555 declining with 129 unchanged. The Health Services industry currently sits down 0.1% versus the S&P 500, which is down 0.1%. Top gainers within the industry include Baxter International ( BAX), up 1.0%, and Smith & Nephew ( SNN), up 0.7%. On the negative front, top decliners within the industry include ResMed ( RMD), down 3.2%, St Jude Medical ( STJ), down 1.7% and Becton Dickinson ( BDX), down 0.8%. TheStreet Ratings group would like to highlight 3 stocks pushing the industry higher today: 3. Fresenius Medical Care Corporation ( FMS) is one of the companies pushing the Health Services industry higher today. As of noon trading, Fresenius Medical Care Corporation is up $0.51 (0.8%) to $67.17 on average volume Thus far, 37,976 shares of Fresenius Medical Care Corporation exchanged hands as compared to its average daily volume of 72,700 shares. The stock has ranged in price between $67.04-$67.63 after having opened the day at $67.41 as compared to the previous trading day's close of $66.66. Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides products and services for the treatment of end-stage renal disease worldwide. The company owns and operates dialysis clinics that provide dialysis treatment, and related laboratory and diagnostic services. Fresenius Medical Care Corporation has a market cap of $20.2 billion and is part of the health care sector. The company has a P/E ratio of 19.1, above the S&P 500 P/E ratio of 17.7. Shares are down 1.6% year to date as of the close of trading on Friday. Currently there are 5 analysts that rate Fresenius Medical Care Corporation a buy, no analysts rate it a sell, and 7 rate it a hold. TheStreet Ratings rates Fresenius Medical Care Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, good cash flow from operations, expanding profit margins and reasonable valuation levels. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Fresenius Medical Care Corporation Ratings Report now.